Skip to main content
. 2021 Oct 11;62(12):3005–3015. doi: 10.1111/epi.17091

FIGURE 2.

FIGURE 2

Responder rates during the entire maintenance phase among all patients (maintenance population, n = 214) and patients continuing cenobamate at data cutoff (n = 177). The median treatment duration for all patients in the maintenance population was 29.5 months. The median treatment duration for patients continuing cenobamate at data cutoff was 30.2 months